DCF — ST. JOHNS RIVERSIDE HOSPITAL
Enterprise Value: $-236.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-236.9M
Enterprise Value
$-79.2M
PV of Cash Flows
$-157.7M
PV of Terminal Value
$-253.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $275.9M | $-12.4M | -4.0% | $-24.1M | $-21.9M |
| Year 2 | $284.2M | $-9.9M | -3.0% | $-22.0M | $-18.2M |
| Year 3 | $292.7M | $-7.3M | -2.0% | $-19.7M | $-14.8M |
| Year 4 | $301.5M | $-6.0M | -2.0% | $-18.8M | $-12.8M |
| Year 5 | $310.5M | $-5.4M | -2.0% | $-18.6M | $-11.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-236.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$267.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999832015896
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5